Medtronic Global SYMPLICITY Registry Shows Strong Safety Profile of the Symplicity(TM) Renal Denervation System

[Thomson Reuters ONE] – Six-Month Analysis of First 1,000 Patients Enrolled in Real-World Patient Registry Presented at ACC.14 MINNEAPOLIS and WASHINGTON, D.C. – March 30, 2014 – Medtronic, Inc. (NYSE: MDT), announced today further … more

View todays social media effects on MDT

View the latest stocks trending across Twitter. Click to view dashboard

See who Medtronic is hiring next, click here to view